Hal K Berman Selected Research

Immunotherapy

10/2023

Safety, Immunologic, and Clinical Activity of Durvalumab in Combination with Olaparib or Cediranib in Advanced Leiomyosarcoma: Results of the DAPPER Clinical Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hal K Berman Research Topics

Disease

15	Neoplasms (Cancer) 10/2023 - 11/2007
5	Breast Neoplasms (Breast Cancer) 01/2022 - 12/2011
3	Carcinogenesis 01/2021 - 03/2005
2	Melanoma (Melanoma, Malignant) 01/2023 - 12/2022
2	Noninfiltrating Intraductal Carcinoma (DCIS) 05/2010 - 11/2007
1	Leiomyosarcoma 10/2023
1	Disease Progression 10/2023
1	Skin Neoplasms (Skin Cancer) 12/2022
1	Squamous Cell Carcinoma (Epidermoid Carcinoma) 12/2022
1	Genomic Instability 01/2021
1	Carcinoma (Carcinomatosis) 07/2014
1	Hyperplasia 12/2011
1	Neoplastic Processes 03/2005

Drug/Important Bio-Agent (IBA)

4	Biomarkers (Surrogate Marker)IBA 12/2022 - 11/2007
4	DNA (Deoxyribonucleic Acid)IBA 01/2021 - 10/2016
2	Immune Checkpoint InhibitorsIBA 10/2023 - 01/2021
2	LipidsIBA 01/2023 - 12/2022
2	pembrolizumabIBA 01/2022 - 01/2021
2	ParaffinIBA 10/2016 - 05/2010
2	AntioxidantsIBA 02/2015 - 07/2013
2	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 05/2010 - 03/2005
1	durvalumabIBA 10/2023
1	cediranib (AZD2171)IBA 10/2023
1	olaparibIBA 10/2023
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 10/2023
1	Melanins (Melanin)IBA 12/2022
1	HydrogelsIBA 01/2022
1	Circulating Tumor DNAIBA 01/2021
1	Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)IBA 01/2021
1	1,2- di- (4- sulfamidophenyl)- 4- butylpyrazolidine- 3,5- dione (DSB)IBA 01/2021
1	Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)IBA 01/2021
1	Formaldehyde (Formol)FDA Link 10/2016
1	CarcinogensIBA 03/2015
1	Glutathione (Reduced Glutathione)IBA 02/2015
1	ThioredoxinsIBA 02/2015
1	AntibodiesIBA 02/2015
1	Cyclin D1IBA 07/2014
1	CyclinsIBA 07/2014
1	Messenger RNA (mRNA)IBA 06/2014
1	Proteins (Proteins, Gene)FDA Link 06/2014
1	Estrogens (Estrogen)FDA Link 07/2013
1	Small Interfering RNA (siRNA)IBA 01/2013
1	Jagged-1 ProteinIBA 01/2013
1	Phosphotransferases (Kinase)IBA 01/2013
1	LigandsIBA 01/2013
1	Cyclin-Dependent Kinase Inhibitor p16IBA 12/2011
1	Estrogen ReceptorsIBA 05/2010
1	Oncogene Proteins (Oncogene Protein)IBA 05/2010
1	Ki-67 Antigen (Ki 67 Antigen)IBA 05/2010
1	Progesterone Receptors (Progesterone Receptor)IBA 05/2010
1	Epidermal Growth Factor (EGF)IBA 05/2010

Therapy/Procedure

3	Lasers (Laser) 01/2023 - 11/2018
2	Segmental Mastectomy (Lumpectomy) 05/2010 - 11/2007
1	Immunotherapy 10/2023
1	Drug Therapy (Chemotherapy) 01/2021
1	Neoadjuvant Therapy 02/2019